Blow Fill Seal Technology Market Is Anticipated To Reach US$ 7.0 Bn By 2032

blow-fill-seal-technology-market-forecast-2022-2032 (1)

In the upcoming years, the blow-fill seal technology market is anticipated to expand significantly. According to the analysis, the market is expected to grow at a CAGR of about 6% between 2021 and 2031.

Pharmaceuticals, biologics, and other sterile products are aseptically packaged using the blow-fill seal production method. Three of the main drivers propelling the growth of the blow-fill-seal technology market are the expanding acceptance of prefilled syringes, the rising demand for aseptic packaging solutions, and the rising investments in the pharmaceutical sector.

In the upcoming years, the blow-fill seal technology market is anticipated to expand significantly. According to the analysis, the market is expected to grow at a CAGR of about 6% between 2021 and 2031.

Pharmaceuticals, biologics, and other sterile products are aseptically packaged using the blow-fill seal production method. Three of the main drivers propelling the growth of the blow-fill seal technology market are the expanding acceptance of prefilled syringes, the rising demand for aseptic packaging solutions, and the rising investments in the pharmaceutical sector.

Download a Sample Copy of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=3048

Segmentation of Blow Fill Seal Technology Industry Research

  • By Product Type :
    • Bottles
      • 0.2-100ml
      • 100-500ml
      • Above 500ml
    • Ampoules
      • 0.1-10ml
      • 10-100ml
    • Vials
      • 0.1-10ml
      • 10-50ml
    • Prefilled Syringes & Injectable
  • By Material Type :
    • PE
      • LDPE
      • HDPE
    • PP
    • Others (EVOH etc.)
  • By End-Use :
    • Pharmaceuticals
      • Ophthalmic
      • Injectable
      • Biologics
      • Wound Care
      • Respiratory Therapy
    • Food & Beverages
    • Cosmetics & Personal Care
    • Others (Chemicals etc.)
  • By Region :
    • North America
    • Latin America
    • Europe
    • East Asia
    • South Asia & Oceania
    • MEA

Get Customization on this Report for Specific Research Solutions :
https://www.factmr.com/connectus/sample?flag=RC&rep_id=3048

Competitive Landscape

In association with members of the pharmaceutical sector, makers of ampoules, prefilled syringes, and injectable goods provide contract manufacturing services. The primary goals of technology suppliers have remained growing output, expanding capacity, modernizing, and enhancing operational effectiveness. Likewise, firms who want to expand their regional reach continue to turn to cooperation as a key strategy.

  • In December 2021, Woodstock secured a US patent for its Cold BFS system. Because it adjusts temperature to the optimal level to prevent heat-related harm, this method is ideal for medications that are sensitive to heat.
  • In January 2021, Berry Global Healthcare unveiled Cyrano, its lightest blow fill seal closure. It was developed to provide a quick fix for all intravenous and infusion systems while reducing the use of plastic.

Key Companies Profiled

  • Amanta Healthcare Ltd.
  • Unither Pharmaceuticals
  • Catalent, Inc.
  • Curida AS
  • Unipharma LLC
  • Weiler Engineering, Inc.
  • GlaxoSmithKline plc.
  • Takeda Pharmaceuticals International AG
  • Nephron Pharmaceuticals Corporation
  • Horizon Pharmaceuticals, Inc.
  • Brevetti Angela S.R.L.
  • Recipharm AB

Will the Pharmaceutical Sector in the U.S. Drive High Demand for Blow Fill Seal Technology?

The need for blow-fill-seal (BFS) technology is anticipated to be quite strong in the US pharmaceutical industry. One of the industries that uses BFS technology the most is the pharmaceutical sector since it has a number of benefits over conventional packaging techniques for liquid and semi-liquid items. BFS technology enables the production of containers that are reliable, effective, and economical. Lower production costs are achieved by doing away with the requirement for several packing operations and reducing material waste through the continuous, one-step process employed in BFS technology.

Also, because the containers are made in a sterile environment, BFS technology improves product safety by lowering the chance of contamination. BFS technology is anticipated to be in high demand in the pharmaceutical industry due to the growing need for packaging solutions that are both safe and effective.

BFS technology is also anticipated to be in high demand in the pharmaceutical industry due to the rising desire for packaging solutions that are environmentally friendly. Compared to conventional packaging techniques, BFS technology creates containers that are lighter and utilize less material, making them more environmentally friendly. It follows that the need for blow-fill-seal technology in the United States is anticipated to increase significantly in the next years due to the pharmaceutical industry.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583